Abilify and Alamast drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported only by a few people who take Abilify and Alamast together.

The phase IV clinical study analyzes what interactions people who take Abilify and Alamast have. It is created by eHealthMe based on reports of 2 people who take the same drugs from the FDA, and is updated regularly.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.



On Jun, 30, 2022

2 people who take Abilify and Alamast together, and have interactions are studied.


What is Abilify?

Abilify has active ingredients of aripiprazole. It is often used in depression. eHealthMe is studying from 88,845 Abilify users for its effectiveness, alternative drugs and more.

What is Alamast?

Alamast has active ingredients of pemirolast potassium. eHealthMe is studying from 16 Alamast users for its effectiveness, alternative drugs and more.

Number of Abilify and Alamast reports submitted per year:

Abilify and Alamast drug interactions.

Common Abilify and Alamast drug interactions by gender *:

female:

  1. Activities of daily living impaired
  2. Deformity
  3. Pain
  4. Tardive dyskinesia
  5. Abdominal pain
  6. Abdominal pain upper
  7. Acne
  8. Akathisia
  9. Angiotensin converting enzyme decreased
  10. Anhedonia

male:

n/a

* Approximation only. Some reports may have incomplete information.

Do you take Abilify and Alamast?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Abilify and Alamast:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Abilify interactions:

Browse all interactions between Abilify and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on aripiprazole and pemirolast potassium (the active ingredients of Abilify and Alamast, respectively), and Abilify and Alamast (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: